Impact of street drug use, HIV infection, and highly active antiretroviral therapy on reproductive hormones in middle- aged women

Nanette Santoro, Julia H. Arnsten, Donna Buono, Andrea A. Howard, Ellie Schoenbaum

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective: To assess the impact of street drug use and HIV infection on reproductive hormones in 82 women aged 28-56 and 15 HIV-uninfected, regularly cycling premenopausal historical controls. Methods: Prospective, pilot cohort study. Baseline blood samples were assayed for follicle-stimulating hormone (FSH), human chorionic gonadotropin (hCG), prolactin (PRL), thyroid-stimulating hormone (TSH), and estradiol (E2). Menopausal status was defined as premenopause: age<40, not amenorrheic; perimenopause: age>40, not amenorrheic; menopause: age>40, with≥12 months' amenorrhea. Kruskal-Wallis testing was used to compare groups of women sorted by menopausal status and separated by drug use and HIV serostatus. Controls were regularly cycling premenopausal women. Results: Thirty-eight of the 82 women (46%) reported substance abuse, and 47 of the 82 (57%) were HIV infected. TSH did not differ by HIV serostatus or drug use. PRL was elevated in drug users compared with nonusers and healthy volunteers (10.3, 5.9 vs. 6.2 ng/ml, respectively, p = 0.002), with no effect of HIV serostatus. FSH was reduced in each menstrual category related to drug use and in postmenopausal women associated with positive HIV serostatus. Highly active antiretroviral therapy (HAART) use was not related to PRL or E2 but was associated with higher FSH. FSH was greater in cohort participants compared with controls. Conclusions: Drug use, not HIV, relates to increased PRL. Both drug use and HIV infection are associated with decreased FSH. Women in this socioeconomic stratum at high risk for HIV may be at risk for early menopause. Increased PRL may falsely reduce FSH, necessitating a more careful hormonal characterization of menopausal status in this sample of women.

Original languageEnglish (US)
Pages (from-to)898-905
Number of pages8
JournalJournal of Women's Health
Volume14
Issue number10
DOIs
StatePublished - Dec 2005

Fingerprint

Highly Active Antiretroviral Therapy
Street Drugs
HIV Infections
Follicle Stimulating Hormone
HIV
Hormones
Prolactin
Pharmaceutical Preparations
Thyrotropin
Menopause
Premenopause
Amenorrhea
Chorionic Gonadotropin
Drug Users
Substance-Related Disorders
Estradiol
Healthy Volunteers
Cohort Studies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Impact of street drug use, HIV infection, and highly active antiretroviral therapy on reproductive hormones in middle- aged women. / Santoro, Nanette; Arnsten, Julia H.; Buono, Donna; Howard, Andrea A.; Schoenbaum, Ellie.

In: Journal of Women's Health, Vol. 14, No. 10, 12.2005, p. 898-905.

Research output: Contribution to journalArticle

@article{db3c4fda36344508ab2066ffb12e9d66,
title = "Impact of street drug use, HIV infection, and highly active antiretroviral therapy on reproductive hormones in middle- aged women",
abstract = "Objective: To assess the impact of street drug use and HIV infection on reproductive hormones in 82 women aged 28-56 and 15 HIV-uninfected, regularly cycling premenopausal historical controls. Methods: Prospective, pilot cohort study. Baseline blood samples were assayed for follicle-stimulating hormone (FSH), human chorionic gonadotropin (hCG), prolactin (PRL), thyroid-stimulating hormone (TSH), and estradiol (E2). Menopausal status was defined as premenopause: age<40, not amenorrheic; perimenopause: age>40, not amenorrheic; menopause: age>40, with≥12 months' amenorrhea. Kruskal-Wallis testing was used to compare groups of women sorted by menopausal status and separated by drug use and HIV serostatus. Controls were regularly cycling premenopausal women. Results: Thirty-eight of the 82 women (46{\%}) reported substance abuse, and 47 of the 82 (57{\%}) were HIV infected. TSH did not differ by HIV serostatus or drug use. PRL was elevated in drug users compared with nonusers and healthy volunteers (10.3, 5.9 vs. 6.2 ng/ml, respectively, p = 0.002), with no effect of HIV serostatus. FSH was reduced in each menstrual category related to drug use and in postmenopausal women associated with positive HIV serostatus. Highly active antiretroviral therapy (HAART) use was not related to PRL or E2 but was associated with higher FSH. FSH was greater in cohort participants compared with controls. Conclusions: Drug use, not HIV, relates to increased PRL. Both drug use and HIV infection are associated with decreased FSH. Women in this socioeconomic stratum at high risk for HIV may be at risk for early menopause. Increased PRL may falsely reduce FSH, necessitating a more careful hormonal characterization of menopausal status in this sample of women.",
author = "Nanette Santoro and Arnsten, {Julia H.} and Donna Buono and Howard, {Andrea A.} and Ellie Schoenbaum",
year = "2005",
month = "12",
doi = "10.1089/jwh.2005.14.898",
language = "English (US)",
volume = "14",
pages = "898--905",
journal = "Journal of Women's Health",
issn = "1540-9996",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - Impact of street drug use, HIV infection, and highly active antiretroviral therapy on reproductive hormones in middle- aged women

AU - Santoro, Nanette

AU - Arnsten, Julia H.

AU - Buono, Donna

AU - Howard, Andrea A.

AU - Schoenbaum, Ellie

PY - 2005/12

Y1 - 2005/12

N2 - Objective: To assess the impact of street drug use and HIV infection on reproductive hormones in 82 women aged 28-56 and 15 HIV-uninfected, regularly cycling premenopausal historical controls. Methods: Prospective, pilot cohort study. Baseline blood samples were assayed for follicle-stimulating hormone (FSH), human chorionic gonadotropin (hCG), prolactin (PRL), thyroid-stimulating hormone (TSH), and estradiol (E2). Menopausal status was defined as premenopause: age<40, not amenorrheic; perimenopause: age>40, not amenorrheic; menopause: age>40, with≥12 months' amenorrhea. Kruskal-Wallis testing was used to compare groups of women sorted by menopausal status and separated by drug use and HIV serostatus. Controls were regularly cycling premenopausal women. Results: Thirty-eight of the 82 women (46%) reported substance abuse, and 47 of the 82 (57%) were HIV infected. TSH did not differ by HIV serostatus or drug use. PRL was elevated in drug users compared with nonusers and healthy volunteers (10.3, 5.9 vs. 6.2 ng/ml, respectively, p = 0.002), with no effect of HIV serostatus. FSH was reduced in each menstrual category related to drug use and in postmenopausal women associated with positive HIV serostatus. Highly active antiretroviral therapy (HAART) use was not related to PRL or E2 but was associated with higher FSH. FSH was greater in cohort participants compared with controls. Conclusions: Drug use, not HIV, relates to increased PRL. Both drug use and HIV infection are associated with decreased FSH. Women in this socioeconomic stratum at high risk for HIV may be at risk for early menopause. Increased PRL may falsely reduce FSH, necessitating a more careful hormonal characterization of menopausal status in this sample of women.

AB - Objective: To assess the impact of street drug use and HIV infection on reproductive hormones in 82 women aged 28-56 and 15 HIV-uninfected, regularly cycling premenopausal historical controls. Methods: Prospective, pilot cohort study. Baseline blood samples were assayed for follicle-stimulating hormone (FSH), human chorionic gonadotropin (hCG), prolactin (PRL), thyroid-stimulating hormone (TSH), and estradiol (E2). Menopausal status was defined as premenopause: age<40, not amenorrheic; perimenopause: age>40, not amenorrheic; menopause: age>40, with≥12 months' amenorrhea. Kruskal-Wallis testing was used to compare groups of women sorted by menopausal status and separated by drug use and HIV serostatus. Controls were regularly cycling premenopausal women. Results: Thirty-eight of the 82 women (46%) reported substance abuse, and 47 of the 82 (57%) were HIV infected. TSH did not differ by HIV serostatus or drug use. PRL was elevated in drug users compared with nonusers and healthy volunteers (10.3, 5.9 vs. 6.2 ng/ml, respectively, p = 0.002), with no effect of HIV serostatus. FSH was reduced in each menstrual category related to drug use and in postmenopausal women associated with positive HIV serostatus. Highly active antiretroviral therapy (HAART) use was not related to PRL or E2 but was associated with higher FSH. FSH was greater in cohort participants compared with controls. Conclusions: Drug use, not HIV, relates to increased PRL. Both drug use and HIV infection are associated with decreased FSH. Women in this socioeconomic stratum at high risk for HIV may be at risk for early menopause. Increased PRL may falsely reduce FSH, necessitating a more careful hormonal characterization of menopausal status in this sample of women.

UR - http://www.scopus.com/inward/record.url?scp=31344473968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31344473968&partnerID=8YFLogxK

U2 - 10.1089/jwh.2005.14.898

DO - 10.1089/jwh.2005.14.898

M3 - Article

C2 - 16372891

AN - SCOPUS:31344473968

VL - 14

SP - 898

EP - 905

JO - Journal of Women's Health

JF - Journal of Women's Health

SN - 1540-9996

IS - 10

ER -